Gastric cardia carcinoma used to be classified as esophageal carcinoma or gastric carcinoma in tumor registry. Thanks to the progress in endoscopy screening and pathologic diagnosis, it has been identified as a distinct entity in recent years. Generally, the occurrence of tumor is a result of the coaction of environmental and genetic factors. Besides some genetic changes, phenogenetic changes, such hypermethylation of tumor suppressor genes (TSGs), are now also considered to be involved in tumor occurrence and development and may be early events of this process.
2 Thrombospondin1 (TSP1) is an endogenous tumor vascularization regulator. Recent studies suggested that TPS1, as a candidate TSG, could inhibit vascularization in tumors. 3 In many tumors, hypermethylation may silence this gene. However, no report has described its methylation status in gastric cardia adenocarcinoma (GCA). In the meantime, TPS1 is an important endogenous activator for TGF茁 1. Absence of TSP1 expression can lead to the loss of its activation on TGF茁 1, whereas TGF茁 1, as an important cytokine in the body, is involved in many aspects of tumor immunity, such as inhibiting T cell proliferation and promoting vascularization. 4 In this study, we examined the methylation status of TSP1 gene and explored its correlation with serum TGF茁 1 level and Tcell immunity in GCA, so as to have more understanding on the methylation status of TSP1 gene promoter in GCA, and to see whether TSP1 gene methylation and deactivation are related with TGF茁 1 level, to investigate the role of TSP1 gene methylation in the occurrence and development of GCA. Of these patients, 73 were men and 23 women, with a median age of 56.5 years (range, 3878 years). All patients did not receive preoperative chemotherapy and radiotherapy. Before resection, two blood samples were taken from each patient via peripheral vein after fasting; one was anticoagulated and used for extraction of monocytes for the analysis on Tcell immunity, and the other was not anticoagulated and was separated for serum, which was preserved at 80益 for subsequent experiments. Tissue specimens were obtained from primary GCA lesion and normal tumoradjacent mucosa in each patient, and were fixed in 10% neutral formaldehyde, paraffined and preserved as routine, then used for DNA extraction and immunohistochemical staining. Both tumor tissue and tumoradjacent tissue were pathologically confirmed. Of the 96 cases of GCA, according to the TNM staging system by UICC, 7 (7.3%) were at stage 玉, 35 (36.5% ) at stage 域 , 39 (40.6% ) at stage 芋 , and 15 (15.6% ) at stage 郁 ; 43 (44.8% ) were well differentiated, 35 (36.4%) were moderately differentiated, and 18 (18.8% ) were poorly differentiated. During the same period, anticoagulated and non anticoagulated peripheral blood samples were obtained from 30 healthy individuals as controls, of which 16 were men and 14 women, with a median age of 51 years (range, 2970 years).
Reagents and apparatuses
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Each specimen was prepared into 1020 sections (10 滋 m), then digested by protease K as routine. Genomic DNA was extracted from cancer tissue and normal adjacent tissue using phenolchloroform method. An amount of 5 滋 g DNA was obtained from each specimen and was denatured with 2 mol/L NaOH, 5 then incubated in 10 mmol/L quinhydrone and 3 mol/L sodium bisulfite at 50益 for 16 h. Wizard DNA purification kit was used to purify the DNA sample that had been treated with sodium bisulfite. Primers used for the detection of methylated TSP1 were 5'TGCGAGCGTTTTTTTAAATGC3' (upstream primer) and 5'TAAACTCGCAAACCAACTCG3' (downstream primer) (74 bp); primers for detection of unmethylated TSP1 were 5'GTTTGGTTGTTGTTTATTGGTTG3' (upstream primer) and 5' CCTAAACTCACAAACCAACTCA3' (downstream primer) (115 bp). The reaction was catalyzed under 95益 for 10 min for predenaturation, and then 35 cycles of 30 s at 94益 for denaturation, 30 s at 62益 for annealing and 30 s at 72益 for elongation, and finally 72益 for 10 min for further elongation. The amplified product underwent electrophoresis in 2% agarose gel. Image analyses were conducted by UV gel electrophoresis imaging and analyzing system. As positive control for MSP, genomic DNA was treated by methylase ( I; New England BioLabs, Inc., Beverly, MA) and was then used in PCR; as negative control, sterile doubledistilled water was used in replacement of DNA template in PCR. As quality control for the MSP measurement, 10% of the samples were randomly selected for repeated experiments.
Paraffin section was deparaffinated and hydrated as routine. Endogenous peroxydase was blocked with 3% methanol and H 2 O 2 . The section was then recovered by microwave for 15 min. Primary antibody, corresponding biotinylated secondary antibody and horseradish peroxidaselabeled third antibody were consecutively added. The section was then treated with DAB, and cell nuclei were counterstained with hematoxylin. Routine dehydration, vitrification, and sealing with neutral gum were performed. PBS was used in replacement of primary antibody as blank control. Normal gastric mucosal tissue was used as positive control.
Serum concentrations of total TGF茁 1 and active TGF茁 1 were measured respectively as described in the protocol of TGF茁 1 immunohistochemical detection reagent kit. The serum samples treated by 1 mol/L hydrochloric acid were used for total TGF茁 1 detection, while untreated serum samples were used for active TGF茁 1 detection. MSP analysis was performed for 96 GCA specimens and corresponding adjacent tissues (Fig. 1 ). TSP1 gene methylation rate was significantly higher in GCA tissues than in normal adjacent tissues (35.4% vs. 3.1% , <0.001), and significantly higher in stage 芋 -郁 GCA tissues than in stage 玉-域 GCA tissues (字 2 =4.40, =0.04); the differences between well, moderately and poorly differentiated tumors were not significant (字 2 =1.19, =0.55) ( Table 1) .
Immunohistochemically stained TSP1 protein was seen in cytoplasm and/or matrix (Fig. 2) . The positive rate of TSP1 protein was significantly lower in GCA specimens than in corresponding adjacent tissues (71.9% vs. 100%, <0.001), and significantly lower in stage 芋-郁 GCA tissues than in stage 玉-域 GCA tissues (字 2 =4.85, =0.03), whereas the differences between well, moderately and poorly differentiated cancers were not significant. All the tumor tissues without TSP1 hypermethylation showed TSP1 protein expression, indicating significant correlation between methylation of TSP1 gene promoter and absent expression of TSP1 protein ( <0.01).
Serum concentration of total TGF茁 1 was significantly higher in GCA patients than in normal controls [(17.2 依 6.0) 滋 g/L vs. (11.9依 3.1) 滋 g/L, <0.05]; however, the difference in concentration of active TGF茁 1 was not significant [(8.2依 5 
>0.05]. Serum concentration of total TGF茁 1 was significantly higher in stage 芋-郁 GCA tissues than in stage 玉-域GCA tissues ( <0.05). The differences in serum concentration of total and active TGF茁 1 between the GCA tissues with and without TSP1 methylation were not significant ( >0.05) ( (Table 3) .
TSP1 is a member of thrombospondin family, which includes five members. TSP1 and TSP2 are trimers, while TSP3, TSP4 and TSP5 are pentamers. These proteins are highly homologous, but they are expressed at different levels in different tissues due to varied promoters. In 1971, TSP1 was identified as a glycoprotein with high molecular weight (450 000). Initial studies demonstrated that TSP1 was produced and secreted by platelets, but subsequent studies found that it could also be produced and secreted by fibroblasts, monocytes, macrophages, smooth muscle cells and some kinds of tumor cells. 68 In physiological circumstance, serum concentration of TSP1 ranges from 60 to 300 ng/mL. 9 TSP1 is involved in numerous physiological processes, including cell adhesion, migration and proliferation, intercellular interaction, vascularization, tumor cell metastasis, inflammation and hemagglutination. 10, 11 Studies suggested that TSP1 produced by breast cancer cell line could inhibit tumor progresssion, and that TSP1 expression was negatively related to the malignant progression of melanoma, lung cancer and breast cancer. 12, 13 Studies have proven that TSP1 was an endogenous vascularization inhibitor, which could induce apoptosis in endothelial cells in vitro, and inhibit neovascularization in vivo and invasive growth.
12 TSP1 has complicated action mechanisms. It can bind to CD36 receptors on the surface of capillary vessels and thus exerts its effect in counteracting vascularization; it can also bind to the precursor of TGFβ and thereby releases active TGFβ in a direct or indirect manner, whereas TGFβ promotes tumor growth and invasion by stabilizing the vacular system in the tumors. 4 Some studies demonstrated that hypermethylation of TSP1 gene led to absent expression of this protein in many tumors, and was thereby involved in the occurrence and development of tumors.
14,15
But studies regarding TSP1 methylation status in GCA are rare.
Our study found highly frequent methylation of TSP1 gene (35.4%) in GCA tissues, together with absent expression of TSP1 protein, indicating that gene silence, which was resulted from methylation of TSP1 gene promoter, might be one important reason for the deactivation of this gene in GCA. TSP1 protein expression in GCA tissues was significantly lower than that in normal adjacent tissues, but protein expression could be positive even in tumor tissues with TSP1 methylation. Confounding normal tissues in tumor tissues might be one reason, and heterogeneous gene methylation and allele methylation might be another important reason. In our study, we also found positive protein expression in GCA tissues with methylation, indicating incomplete methylaiton. In addition, DNA methylation was currently considered to inhibit gene expression on transcription level. Some studies suggested that density of CpG island methylation was correlated the inhibition level on transcription; 16 a weak promoter might be completely inhibited by lower density of methylation, but when the promoter was enhanced by an enhancer, transcription activity could be partially restored. In some tumor tissues, the methylation level of TSP1 gene promoter might not be enough to inhibit transcription, leading to a scenario where gene is methylated but protein expression is still positive.
TGFβ family exerts important biological effects via TGFβ /Smad signal transduction pathway; they regulate cell proliferation, differentiation, apoptosis, migration and adhesion and the production of extracellular matrix, and also have important roles in embryonic development, repairing mature tissue and immunity regulation. 4 TGF茁 is a strong inhibitor on cell growth. It inhibits cell growth by changing the expression or functions of cell cycle regulators. During the occurrence of tumors, TGFβ has biphasic e ffects. At early stages when cells are still responsive to the antiproliferation effect of TGF茁 , it 10 Our study found that serum TGF茁 1 level was significantly elevated in patients with GCA, and also significantly increased with tumor progression, suggesting close correlation between serum TGF茁 1 concentration and the occurrence, development, infiltration and metastasis of GCA. As an important endogenous activator of TGF茁 1, TSP1 contacts and reacts with TGF茁 1 latency associated peptide (LAP) and leads to the dissociation of the noncovalent bond between TGF茁 1 and LAP; moreover, the binding of TSP1 and TGF茁 1 prevents TGF茁 1 from binding to its receptor and thus makes it inert. To examine whether TSP1 influenced the activation of TGF茁 1 in GCA patients, we analyzed serum concentration of active TGF茁 1 in GCA patients. The results showed that, although active TGF茁 1 concentration in patients with TSP1 methylation was lower than those without TSP1 methylation, the difference was not significant. However, in the study on colon cancer cell line, Rojas . 15 found that TSP1 demethylation resulted in increased concentration of active TGF茁 1 in the supernatant of cell culture. The reason for such inconsistence might be, first of all, the different types of tumor used in the studies: our study detected the serum active TGF茁 1 concentration in the peripheral blood from GCA patients, while Rojas . detected active TGF茁 1 concentration in the supernatant of colon cancer cell culture. In addition, influential factors for in vitro cell culture were simple, while with the complicated signal tranduction pathways in vivo, the activation and secretion of TGF茁 1 might be regulated by multiple genes. The influence of TSP1 methylation alone on the activation of TGF茁 1 was not obvious enough to be seen in peripheral blood. This also demonstrated that the occurrence and development of GCA was a result of the multistage coaction involving numerous genes.
Host antitumor immunity is mainly seen as cell immunity. T cell subgroups are important in maintaining immune surveillance over tumors, and are also important effector cells in the antitumor immunity of the body. In a healthy individual, the immune system is in stable balance, containing a lot of effector T lymphocytes and also inhibitory T lymphocytes, namely Treg cells. Using serial CD monoclonal antibody (mAb), we can recognize the antigenic determinant on the surface of T lymphocytes. Among these CD markers, CD3 is a surface marker for mature T cells, while CD4 and CD8 are surface markers of T helper cells (Th) and cytotoxic T cells (Tc), respectively. Decreased CD3 cells and inverted CD4/CD8 ratio generally reflect depressed cell immunity in the body. Treg cells were increased, and cell immunity was further impaired as the tumor progressed; in addition, cell immunity was significantly correlated to serum TGF茁 1 concentration. Further analysis revealed that cell immunity in GCA patients with TSP1 methylation was remarkably lower than in those without TSP1 methylation, suggesting that methylation deactivated TSP1 and thus affected its inhibition on vascularization. As a result, the normal balance of vascularization was interrupted, and cytokines that inhibited immunity and promoted vascularization, such as TGF茁 1, were increased. In turn, TGF茁 1 inhibited cell immunity in tumor patients by inhibiting the proliferation of Th cells and inducing the production of Treg cells, and thus helped tumor cells escape from the immune surveillance in the body and promoted occurrence, development, infiltration and metastasis of the tumors. 
